Top Authors

• Most frequent coverage on GENZ

• 
  Mike Havrilla (1926 followers)

  • BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte (Fri, Sep 25)
  • Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk (Wed, Sep 23)
  • FDA Calendar Updates: Orexo, Novo Nordisk, King, Isis, Facet (Fri, Aug 7)

  More by Mike Havrilla on GENZ »
• 
  SA Editor Miriam Metzinger (537 followers)

  • Cramer's Lightning Round - Elan Is Too Dicey (6/18/09) (Fri, Jun 19)
  • Fast Money Recap: Mister Softee No More? (6/16/09) (Wed, Jun 17)
  • Cramer's Stop Trading! JP Morgan's Secondary a Bit Too Expensive (6/2/09) (Wed, Jun 3)

  More by SA Editor Miriam Metzinger on GENZ »
• 
  Mark Mitchell (42 followers)

  • Genzyme: Positive Development on the Lumizyme Front (Thu, Dec 3)
  • Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate (Wed, Nov 25)
  • Lumizyme Rejected Again: Downgrading Genzyme Recommendation from Buy to Hold (Tue, Nov 17)

  More by Mark Mitchell on GENZ »

• Most followed authors on GENZ

• 
  Philip Davis (5867 followers)

  • Options Trader: August Retrospective (Sat, Aug 29)
  • Options Trader: Wednesday Outlook (Wed, Jun 17)

  More by Philip Davis on GENZ »
• 
  Bespoke Investment Group (3520 followers)

  • Best and Worst Since the March 9th Low (Fri, Dec 11)
  • Best Analyst Ratings in the S&P 500 (Wed, May 20)
  • Stocks with the Most Buy and Sell Recommendations (Tue, Apr 21)

  More by Bespoke Investment Group on GENZ »
• 
  Don Dion (2768 followers)

  • Is IBB the Best Biotech ETF? (Thu, Jul 2)
  • IBB: Newfound Stability Lures Biotech Investors (Wed, Feb 18)
  • Big Biotech Booms But IBB Falls Flat (Wed, Jul 16)

  More by Don Dion on GENZ »

• Newest authors on GENZ

• 
  Ken Majmudar (10 followers)

  • Genzyme: Short Term Traders Are Throwing Out the Baby with the Bathwater (Wed, Sep 16)

  More by Ken Majmudar on GENZ »
• 
  R. Saito (29 followers)

  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval (Wed, Aug 26)

  More by R. Saito on GENZ »
• 
  BioPharma Investor (76 followers)

  • Protalix Biotherapeutics: FDA Fast Track for Gaucher Treatment (Wed, Aug 26)

  More by BioPharma Investor on GENZ »

• Most commented on GENZ

• 
  Mike Havrilla (1926 followers)

  • BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte (Fri, Sep 25)
  • Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk (Wed, Sep 23)
  • FDA Calendar Updates: Orexo, Novo Nordisk, King, Isis, Facet (Fri, Aug 7)

  More by Mike Havrilla on GENZ »
• 
  SA Editor Rachael Granby (2022 followers)

  • Wall Street Breakfast: Must-Know News (Wed, Jun 17)
  • Wall Street Breakfast: Must-Know News (Wed, Feb 11)

  More by SA Editor Rachael Granby on GENZ »
• 
  Mark Mitchell (42 followers)

  • Genzyme: Positive Development on the Lumizyme Front (Thu, Dec 3)
  • Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate (Wed, Nov 25)
  • Lumizyme Rejected Again: Downgrading Genzyme Recommendation from Buy to Hold (Tue, Nov 17)

  More by Mark Mitchell on GENZ »